Welcome to our dedicated page for Alchemy Investments Acquisition 1 SEC filings (Ticker: ALCWF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Alchemy Investments Acquisition 1's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Alchemy Investments Acquisition 1's regulatory disclosures and financial reporting.
Alchemy Investments Acquisition Corp 1 notified Nasdaq Stock Market LLC that its Class A Ordinary Shares, Units, and Warrants are being removed from listing and/or withdrawn from registration. The Exchange certified the action pursuant to 17 CFR 240.12d2-2(b) and the issuer confirmed voluntary withdrawal pursuant to 17 CFR 240.12d2-2(c).
The notification identifies Nasdaq as the Exchange and lists the issuer's principal office at 850 Library Avenue, Suite 204-F, Newark, Delaware 19711.
Alchemy Investments Acquisition Corp 1 reported a Q1 2026 net loss of $331,900 as it continues to search for a target and close its announced merger with Cartiga.
The SPAC held $8.96 million in its Trust Account and only $86,243 in cash outside the trust, resulting in a working capital deficit of $3.91 million and substantial doubt about its ability to continue as a going concern without completing a deal.
Alchemy has a Business Combination Agreement to acquire Cartiga at an equity value of $540 million using an Up‑C structure, with closing conditioned on shareholder approvals, a Nasdaq listing and at least $40 million of available closing cash unless waived. Sponsor loans totaled $2.0 million and the company continues making monthly deposits to extend its deadline to complete a transaction to September 9, 2026.